Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural analgesia during early epiphyseal distraction for Blount disease surgery
2010-022606-41Phase 3Active
- Sponsor
- CHU de Martinique
- Start
- Sep 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ropivacaine in Blount disease, sponsored by CHU de Martinique. Primary endpoint: Completion rate of epidural anesthesia. Started Sep 2010; status: active.
02
Drugs
ropivacaine
03
Conditions
Blount disease
Beyond the preview
Go deeper on 2010-022606-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022606-41.